Literature DB >> 9266108

BRCA2 hereditary breast cancer pathophenotype.

J N Marcus1, P Watson, D L Page, S A Narod, P Tonin, G M Lenoir, O Serova, H T Lynch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9266108     DOI： 10.1023/a:1005830230664

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  12 in total

1.  The pathology of hereditary breast cancer.

Authors:  Emiliano Honrado; Javier Benítez; José Palacios
Journal:  Hered Cancer Clin Pract       Date:  2004-07-15       Impact factor: 2.857

Review 2.  BRCA mutation testing in determining breast cancer therapy.

Authors:  Karen Lisa Smith; Claudine Isaacs
Journal:  Cancer J       Date:  2011 Nov-Dec       Impact factor: 3.360

3.  Multimodality breast cancer screening in women with a familial or genetic predisposition.

Authors:  I Trop; L Lalonde; M H Mayrand; J David; N Larouche; D Provencher
Journal:  Curr Oncol       Date:  2010-06       Impact factor: 3.677

4.  High-Mobility Group A (HMGA) Proteins and Breast Cancer.

Authors:  Silvia Peluso; Gennaro Chiappetta
Journal:  Breast Care (Basel)       Date:  2010-04-09       Impact factor: 2.860

Review 5.  Historical and epidemiologic background of human premalignant breast disease.

Authors:  D L Page; R A Jensen; J F Simpson; W D Dupont
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

6.  Familial breast cancer: an investigation into the outcome of treatment for early stage disease.

Authors:  D Eccles; P Simmonds; J Goddard; M Coultas; S Hodgson; F Lalloo; G Evans; N Haites
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

7.  Stemming the tide of cancer for BRCA1/2 mutation carriers.

Authors:  Henry T Lynch; Joseph N Marcus; Wendy S Rubinstein
Journal:  J Clin Oncol       Date:  2008-09-10       Impact factor: 44.544

8.  Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer.

Authors:  Tomasz Byrski; Rebecca Dent; Pawel Blecharz; Malgorzata Foszczynska-Kloda; Jacek Gronwald; Tomasz Huzarski; Cezary Cybulski; Elzbieta Marczyk; Robert Chrzan; Andrea Eisen; Jan Lubinski; Steven A Narod
Journal:  Breast Cancer Res       Date:  2012-07-20       Impact factor: 6.466

Review 9.  Pathology of hereditary breast cancer.

Authors:  Petra van der Groep; Elsken van der Wall; Paul J van Diest
Journal:  Cell Oncol (Dordr)       Date:  2011-02-19       Impact factor: 6.730

10.  A common missense variant in BRCA2 predisposes to early onset breast cancer.

Authors:  Bohdan Górski; Steven A Narod; Jan Lubinski
Journal:  Breast Cancer Res       Date:  2005-10-24       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.